DN
Publications
82
Views
14,169
Downloads
5,981
Supervised works
2
Items per page
1 - 82 of 82
Title Published in Access level OA Policy Year Views Downloads
The Importance of MRI in the Early Diagnosis of Acute Invasive Fungal RhinosinusitisDiagnostics
accessLevelPublic
2025 92 16
Antifungal treatment duration in hematology patients with invasive mold infections : a real-life updateOpen forum infectious diseases
accessLevelPublic
2024 42 24
Isavuconazole for the Treatment of Fungal Infections : A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS)Open forum infectious diseases
accessLevelPublic
2024 28 40
Do infectious diseases after kidney retransplantation differ from those after first kidney transplantation ?Open forum infectious diseases
accessLevelPublic
2024 80 26
Pitfalls in Valganciclovir Prophylaxis Dose Adjustment Based on Renal Function in Kidney Transplant RecipientsTransplant international
accessLevelPublic
2024 79 31
BK polyomavirus serotype-specific antibody responses in blood donors and kidney transplant recipients with and without new-onset BK polyomavirus-DNAemia : A Swiss Transplant Cohort StudyAmerican journal of transplantation
accessLevelPublic
2024 17 18
Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella speciesFrontiers in medicine
accessLevelPublic
2024 61 13
Pre-engraftment bacteremia after allogeneic hematopoietic cell transplantation without primary fluoroquinolone antibacterial prophylaxisTransplant infectious disease
accessLevelPublic
2024 33 23
Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation : a longitudinal retrospective multicenter studyBone marrow transplantation
accessLevelPublic
2024 45 13
Pitfalls in definitions on respiratory viruses and particularities of Adenovirus infection in hematopoietic cell transplantation patients : Recommendations from the EBMT practice harmonization and guidelines committeeCurrent research in translational medicine
accessLevelPublic
2024 20 7
Routine infectious disease consultation prior to an allogeneic hematopoietic cell transplantOpen forum infectious diseases
accessLevelPublic
2023 41 37
Comparing the Real-World Use of Isavuconazole to Other Anti-Fungal Therapy for Invasive Fungal Infections in Patients with and without Underlying Disparities : A Multi-Center Retrospective StudyJournal of Fungi
accessLevelPublic
2023 64 43
Vaccine-preventable infections among solid organ transplant recipients in SwitzerlandJAMA network open
accessLevelPublic
2023 91 25
Revisiting cytomegalovirus serology in allogeneic hematopoietic cell transplant recipientsClinical infectious diseases
accessLevelPublic
2023 76 40
Antifungal prophylaxis and pre-emptive therapy : when and how ?Molecular aspects of medicine
accessLevelPublic
2023 53 18
Duration of antifungal treatment in mold infection : when is enough ?Current opinion in infectious diseases
accessLevelPublic
2023 61 9
The present and future of blood virome in allogeneic hematopoietic cell transplant recipientsCurrent opinion in infectious diseases
accessLevelPublic
2023 67 16
Bloodstream infections in allogeneic haematopoietic cell recipients from the swiss transplant cohort study: trends of causative pathogens and resistance ratesBone marrow transplantation
accessLevelPublic
2023 112 46
American Society for Transplantation and Cellular Therapy Series, #6 : Management of Invasive Candidiasis in Hematopoietic Cell Transplantation RecipientsTransplantation and cellular therapy
accessLevelPublic
2023 48 29
CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant RecipientsOpen forum infectious diseases
accessLevelPublic
2023 82 22
Immunogenicity of High-Dose vs. MF59-adjuvanted vs. Standard Influenza Vaccine in Solid Organ Transplant Recipients : The STOP-FLU trialClinical infectious diseases
accessLevelPublic
2023 72 25
Immune monitoring-guided vs fixed duration of antiviral prophylaxis against cytomegalovirus in solid-organ transplant recipients. A Multicenter, Randomized Clinical TrialClinical infectious diseases
accessLevelPublic
2023 110 59
Invasive Aspergillosis and the Impact of Azole-resistanceCurrent fungal infection reports
accessLevelPublic
2023 49 23
Longitudinal Detection of Twenty DNA and RNA Viruses in Allogeneic Hematopoietic Stem Cell Transplant Recipients PlasmaViruses
accessLevelPublic
2023 123 68
Bacteremia During the First Year After Solid Organ Transplantation : An Epidemiological UpdateOpen forum infectious diseases
accessLevelPublic
2023 90 39
Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant RecipientsAntimicrobial agents and chemotherapy
accessLevelPublic
2023 63 135
Hepatitis E Virus Infection Epidemiology in Recipients of Allogeneic Hematopoietic Cell TransplantOpen forum infectious diseases
accessLevelPublic
2023 41 34
Nouveautés dans la prise en charge de l’infection à cytomégalovirus chez les patients transplantésRevue médicale suisse
accessLevelPublic
2023 56 13
Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress?Open forum infectious diseases
accessLevelPublic
2022 242 134
Central nervous system infections in solid organ transplant recipients: Results from the Swiss Transplant Cohort StudyThe Journal of infection
accessLevelPublic
2022 205 103
Atypical pulmonary phaeohyphomycosis due to Aureobasidium spp. - case report and brief literature reviewSwiss medical weekly
accessLevelPublic
2022 150 34
Distribution of Aspergillus Species and Prevalence of Azole Resistance in Respiratory Samples From Swiss Tertiary Care HospitalsOpen forum infectious diseases
accessLevelPublic
2022 197 77
Therapeutic Drug Monitoring of Orally Administered Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant RecipientsAntimicrobial agents and chemotherapy
accessLevelPublic
2022 65 86
Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infectionsMycoses
accessLevelPublic
2022 250 117
Impact of different urinary tract infection phenotypes within the first year post-transplant on renal allograft outcomesAmerican journal of transplantation
accessLevelPublic
2022 154 80
Letermovir for cytomegalovirus primary prophylaxis in a multiple abdominal/small bowel transplant recipientClinical transplantation
accessLevelRestricted
2022 217 0
Epidemiology and outcomes of bone and joint infections in solid organ transplant recipientsAmerican journal of transplantation
accessLevelPublic
2022 180 62
T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipientsAnnals of oncology
accessLevelPublic
2022 153 45
When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients?Mycoses
accessLevelPublic
2022 71 32
Surgical site infections after simultaneous pancreas kidney and pancreas transplantation in the Swiss Transplant Cohort StudyJournal of hospital infection
accessLevelPublic
2022 183 62
Epidemiology and outcomes of medically attended and microbiologically confirmed bacterial foodborne infections in solid organ transplant recipientsAmerican journal of transplantation
accessLevelPublic
2022 171 69
Screening for Parasitic Infection and Tuberculosis in Immunosuppressed and Pre-Immunosuppressed Patients: An Observational StudyTropical medicine and infectious disease
accessLevelPublic
2021 201 104
COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?Clinical microbiology and infection
accessLevelPublic
2021 185 81
Progress and current challenges in the management of invasive fungal infections in hematologic malignancy patients and allogeneic hematopoietic cell transplant recipients
accessLevelPublic
2021 279 401
Letermovir Primary Prophylaxis in High-Risk Hematopoietic Cell Transplant Recipients: A Matched Cohort StudyVaccines
accessLevelPublic
2021 170 160
Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort studyAmerican journal of transplantation
accessLevelPublic
2021 226 100
Predictors of breakthrough clinically significant cytomegalovirus infection during letermovir prophylaxis in high-risk hematopoietic cell transplant recipientsImmunity, inflammation and disease
accessLevelPublic
2021 290 85
Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018Antimicrobial resistance and infection control
accessLevelPublic
2021 319 74
Burden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort studyAmerican journal of transplantation
accessLevelPublic
2021 117 82
Clinical considerations of isavuconazole administration in high-risk hematological patients: a single-center 5-year experienceMycopathologia
accessLevelPublic
2021 208 110
Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipientsMedical mycology
accessLevelRestricted
2021 286 1
Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of responseBMC infectious diseases
accessLevelPublic
2021 122 114
Differences between infectious disease events in first liver transplant versus retransplantation in the Swiss Transplant Cohort StudyLiver transplantation
accessLevelRestricted
2021 113 0
Editorial: Transplant infectious disease landscape in the COVID19-EraCurrent opinion in infectious diseases
accessLevelRestricted
2021 159 0
The EHA research roadmap: infections in hematologyHemaSphere
accessLevelPublic
2021 165 73
Clinical and Pharmacological Considerations for Concomitant Administration of Posaconazole and Isavuconazole with LetermovirAntimicrobial agents and chemotherapy
accessLevelPublic
2021 203 292
Trends of the Epidemiology of Candidemia in Switzerland: A 15-Year FUNGINOS SurveyOpen forum infectious diseases
accessLevelPublic
2021 57 49
Real-life considerations on antifungal treatment combinations for the management of invasive mold infections after allogeneic cell transplantationJournal of Fungi
accessLevelPublic
2021 154 100
Safety and efficacy of intravenously administered cidofovir in adult haematopoietic cell transplant recipients: a retrospective multicentre cohort studyThe journal of antimicrobial chemotherapy
accessLevelRestricted
2021 173 0
Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipientsMedical mycology
accessLevelRestricted
2021 137 0
Invasive aspergillosis due to Aspergillus section Usti: a multicenter retrospective studyClinical Infectious Diseases
accessLevelPublic
2020 198 486
Risk factors for candidemia: a prospective matched case-control studyCritical Care
accessLevelPublic
2020 308 101
Response to "Missed diagnosis and misdiagnosis of infectious diseases in hematopoietic cell transplant recipients: an autopsy study"Blood advances
accessLevelPublic
2020 167 39
Emerging echinocandin-resistant Candida albicans and glabrata in SwitzerlandInfection
accessLevelPublic
2020 205 97
First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort StudyAmerican Journal of Transplantation
accessLevelPublic
2020 258 98
Intracellular Pathogen in the Cerebrospinal Fluid of an Allogeneic Hematopoietic Cell Transplant Recipient With Graft-Versus-Host Disease and Brain LesionsClinical infectious diseases
accessLevelRestricted
2020 235 0
Reasons for voriconazole prophylaxis discontinuation in allogeneic hematopoietic cell transplant recipients: A real-life paradigmMedical Mycology
accessLevelPublic
2020 174 238
Optimal treatment duration of pseudomonas aeruginosa infections in allogeneic hematopoietic cell transplant recipientsOpen Forum Infectious Diseases
accessLevelPublic
2020 427 112
First case of Cryptococcus gattii multilobar pneumonia in Switzerland and associated challengesSwiss Medical Weekly
accessLevelPublic
2020 350 121
Combination treatment with letermovir and ganciclovir for maintenance therapy of multidrug-resistant CMV infection in a liver transplant recipientTransplantation
accessLevelRestricted
2020 315 1
Microbiologically documented infections after adult allogeneic hematopoietic cell transplantation: A 5-year analysis within the Swiss Transplant Cohort studyTransplant Infectious Disease
accessLevelRestricted
2020 357 2
Prophylaxie antimicrobienne et approches thérapeutiques empiriques et préemptives pour la prévention des infections chez les receveurs de greffe allogénique de cellules hématopoïétiques
accessLevelPublic
2020 401 178
Infectiologie sur mesure - 1. Immunogénétique des maladies infectieuses : premiers pasRevue médicale suisse
accessLevelRestricted
2019 238 3
National point prevalence survey on healthcare-associated infections in acute care hospitals, Switzerland, 2017Euro Surveillance
accessLevelPublic
2019 329 128
Antimicrobial prophylaxis and preemptive approaches for the prevention of infections in the stem cell transplant recipient, with analogies to the hematologic malignancy patientInfectious disease clinics of North America
accessLevelPublic
2019 136 164
Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort StudyTransplant Infectious Disease
accessLevelRestricted
2018 490 0
Pentraxin-3 polymorphisms and invasive mold infections in acute leukemia patients receiving intensive chemotherapyHaematologica
accessLevelPublic
2018 221 126
Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS)Clinical Microbiology and Infection
accessLevelPublic
2018 249 176
Efficacy of brincidofovir as prophylaxis against HSV and VZV in hematopoietic cell transplant recipientsTransplant Infectious Disease
accessLevelPublic
2018 264 94
Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort studyTransplant Infectious Disease
accessLevelRestricted
2018 431 0
Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant CohortTransplant Infectious Disease
accessLevelRestricted
2018 353 1
First case of Candida auris in Switzerland: discussion about preventive strategiesSwiss Medical Weekly
accessLevelPublic
2018 465 197
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack